Women with mutations in the human BRCA2 gene (hBRCA2) have an increased risk of developing breast and ovarian cancer throughout their lifetime.hBRCA2 transcribes proteins necessary for gene repair through homologous recombination (HR). This evidence concerns the gene BRCA2 and ovarian cancer.